Rafael Stock Price - RFL

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
After Hours
Last Trade
Last $ 19.38 ◊ 0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type
Rafael Holdings Inc RFL NYSE Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.84 -4.15% 19.38 20.16 18.86 19.90 20.22 16:03:56
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
435 33,873 $ 19.43 $ 658,169 36,505 15.95 - 21.16
Last Trade Time Type Quantity Stock Price Currency
18:30:00 2,222 $ 19.38 USD

Rafael Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 305.90M 15.78M $ -11.65M -0.35 - 15.60M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
332.94k $ - 0.00% 1.00 1.10%

more financials information »

Rafael News

Latest RFL Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical RFL Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week16.4521.1615.9519.5143,4032.9317.81%
1 Month18.3521.1615.9518.7133,1161.035.61%
3 Months18.3521.1615.9518.7133,1161.035.61%
6 Months18.3521.1615.9518.7133,1161.035.61%
1 Year18.3521.1615.9518.7133,1161.035.61%
3 Years18.3521.1615.9518.7133,1161.035.61%
5 Years18.3521.1615.9518.7133,1161.035.61%

Rafael Description

Rafael Holdings includes commercial real estate assets and interests in two clinical-stage pharmaceutical companies backed by a strong and liquid balance sheet. Rafael's real estate holdings are comprised by a 20-story commercial office building and associated parking garage in Newark, New Jersey, an office/data center building in Piscataway, New Jersey and an office condominium in Israel. Rafael's pharmaceutical holdings include interests in two clinical-stage oncology companies - Rafael Pharmaceuticals and LipoMedix. Rafael Pharmaceuticals is developing therapies that exploit the metabolic differences between normal cells and cancer cells in both solid and liquid cancers. LipoMedix is developing liposomal prodrugs designed to enhance the efficacy of certain chemotherapeutic therapies.
Your Recent History
NYSE
RFL
Rafael
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191211 06:23:55